Dr. Martens (LSE:DOCS) Beta: 0.8880 (As of Jun. 25, 2026)


LSE:DOCS Dr. Martens PLC LSE:DOCS
52 GF Score
Price £0.70
GF Value £0.72
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dr. Martens Beta?

Dr. Martens LSE:DOCS +1.30% 52 Beta is 0.8880 as of Jun. 25, 2026. GuruFocus rates LSE:DOCS with a GF Score™ of 52/100 and a GF Value™ of £0.72 (Fairly Valued). The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Dr. Martens's Beta is 0.8880.

Dr. Martens  (LSE:DOCS) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Dr. Martens Beta Related Terms

Dr. Martens Beta Historical Data

* Premium members only.

The historical data trend for Dr. Martens's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Martens Beta Chart

Dr. Martens Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.40 1.03

Dr. Martens Semi-Annual Data
Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.07 0.40 0.70 1.03

LSE:DOCS vs NKE, DECK, ONON: Beta Comparison

For the Footwear & Accessories subindustry, Dr. Martens's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr. Martens Beta vs Manufacturing - Apparel & Accessories Industry

For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's Beta distribution charts can be found below:

* The bar in red indicates where Dr. Martens's Beta falls into.


LSE:DOCS
52GF Score
Dr. Martens PLC LSE:DOCS
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Martens Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.8880 mean?
Dr. Martens (LSE:DOCS) has a Beta of 0.8880 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Dr. Martens and its competitors.
Is Dr. Martens' Beta too high?
Dr. Martens' current Beta is 0.8880. Overall, Dr. Martens has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Beta compare to NKE and DECK?
Dr. Martens' Beta of 0.8880 can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Manufacturing - Apparel & Accessories company?
A good Beta depends on the Manufacturing - Apparel & Accessories industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Dr. Martens and its competitors. Dr. Martens's current Beta is 0.8880. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (LSE:DOCS) is currently considered Fairly Valued. The stock's GF Value™ is £0.72, compared to a current price of £0.70 — trading 2.5% below its estimated fair value. The current Beta is 0.8880. Dr. Martens' overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Dr. Martens (LSE:DOCS), the current Beta is 0.8880 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Martens (LSE:DOCS) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Martens stock appears to be undervalued. The current stock price of £0.70 is trading 2.5% below its estimated GF Value™ of £0.72. GuruFocus considers Dr. Martens to be Fairly Valued.

Key valuation signals for LSE:DOCS:

  • Beta: 0.8880
  • GF Value™: £0.72 vs. price of £0.70 (2.5% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the LSE:DOCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr. Martens Business Description

Address 28 Jamestown Road, Camden, London, GBR, NW1 7BY
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
52GF Score

Get the complete analysis for LSE:DOCS

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.70
Price
£0.72
GF Value